ReviewTranslational andrology and urology2020

Defining risk of micrometastatic disease and tumor recurrence in patients with stage I testicular germ cell tumors.

Ryan P Werntz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.